The global defibrillators market is projected to reach USD 11,784.4 million by 2025 from USD 9,652.2 million in 2019, at a CAGR of 3.4%.
Factors such as the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. However, issues related to the use of implantable and automated external defibrillators and frequent product calls are expected to restrain the growth of the defibrillators market in the forecast period. The defibrillators market has witnessed significant developments in terms of technological advancements and new product developments.
The external defibrillators segment is expected to grow at the highest CAGR from 2019 to 2025
On the basis of products, the defibrillators market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is further segmented into transvenous implantable cardioverter defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillators (S-ICDs). The T-ICDs segment is further classified into single-chamber ICDs, dual-chamber ICDs, and cardiac resynchronization therapy defibrillators (CRT-Ds). The external defibrillators segment is further classified into external defibrillators, and wearable cardioverter defibrillators (WCDs). The external defibrillators segment is expected to grow at the highest CAGR in the forecast period, owing to factors such as the growing focus of key market players on developing easy-to-use defibrillators, increasing support from governments to install AEDs at public places, and rising adoption of WCDs.
The hospitals, clinics, and cardiac centers segment to dominate the global defibrillators market during the forecast period
On the basis of end-users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; pre-hospital care settings; public access markets; alternate care facilities; and home care settings. The hospitals, clinics, and cardiac centers segment is estimated to account for the largest share of the defibrillators market in 2019. A growing number of cardiac implant procedures across the globe and the availability of reimbursements across the developed markets are some of the major factors driving the growth of this segment.
APAC is projected to witness the highest growth during the forecast period
The Asia Pacific defibrillators market is expected to grow at the highest CAGR from 2019 to 2025. Factors such as the rapidly growing aging population, increasing cases of cardiovascular diseases, improving research infrastructure, and growing focus of key market players to expand their presence in this region are driving the growth of the Asia Pacific defibrillators market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights 4.1 Market Overview 4.2 Market, By Type, 2019 vs. 2025 (USD Million) 4.3 Market, By End User, 2019 vs. 2025 (USD Million) 4.4 Market: Geographic Growth Opportunities
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 220.127.116.11 Rising Prevalence of Target Diseases 18.104.22.168 Growing Focus on Providing Public-Access Defibrillators 22.214.171.124 Training & Awareness Programs on Defibrillators 5.2.2 Restraints 126.96.36.199 Issues Related to the Use of Implantable and Automated External Defibrillators 5.2.3 Opportunities 188.8.131.52 Emerging Markets 184.108.40.206 Development of S-Icds and Mri-Compatible Icds & Crt-Ds 5.2.4 Challenges 220.127.116.11 Frequent Product Recalls 18.104.22.168 Lack of Awareness About Sudden Cardiac Arrest in Developing Nations 5.3 Industry Trends 5.3.1 Increasing Pricing Pressure on Market Players 5.3.2 Growing Number of Mergers & Acquisitions Among Market Players 5.3.3 Rising Demand for Automated External Defibrillators in Prehospital Settings 5.4 Regulatory Scenario 5.4.1 External Defibrillators 5.4.2 Implantable Defibrillators
6 Defibrillators Market, By Type 6.1 Introduction 6.2 Implantable Cardioverter Defibrillators 6.2.1 Transvenous Implantable Cardioverter Defibrillators 22.214.171.124 Biventricular Icds/Cardiac Resynchronization Therapy Defibrillators 126.96.36.199.1 Launch of Technologically Advanced Crt-D Devices to Support Market Growth 188.8.131.52 Dual-Chamber Icds 184.108.40.206.1 Dual-Chamber Icds Reduce the Incidence of Inappropriate Shocks 220.127.116.11 Single-Chamber Icds 18.104.22.168.1 Single-Chamber Icds are Associated With the Increased Risk of Inappropriate Shocks 6.2.2 Subcutaneous Implantable Cardioverter Defibrillators 22.214.171.124 S-ICDS Segment to Register the Highest Growth in the ICDS Market 6.3 External Defibrillators 6.3.1 Manual & Semi-Automated External Defibrillators 126.96.36.199 Development of Technologically Advanced Aeds is Negatively Affecting the Market for Manual External Defibrillators 6.3.2 Fully Automated External Defibrillators 188.8.131.52 Increasing Installation of These Devices in Public Places to Drive Market Growth 6.3.3 Wearable Cardioverter Defibrillators 184.108.40.206 Concerns Associated With the Use of Wcds are Expected to Hamper Its Adoption
7 Defibrillators Market, By End User 7.1 Introduction 7.2 Hospitals, Clinics, & Cardiac Centers 7.2.1 Hospitals, Clinics, & Cardiac Centers-Largest End Users of Defibrillators 7.3 Prehospital Care Settings 7.3.1 Rising Funding for Prehospital Emergency Ambulance Services in Developing Countries to Support Market Growth 7.4 Public Access Markets 7.4.1 Rising Incidence of Out-Of-Hospital Cardiac Arrest is Driving the Adoption of Defibrillators 7.5 Alternate Care Facilities 7.5.1 Underdeveloped Infrastructure for Alternate Care in Most European Countries and Emerging Nations to Restrain Market Growth 7.6 Home Care Settings 7.6.1 Increasing Adoption of Home Automated External Defibrillators-Key Factor Driving Market Growth
8 Defibrillators Market, By Region 8.1 Introduction 8.2 North America 8.2.1 US 220.127.116.11 High Adoption Rate of Aeds in the Country to Drive Market Growth 8.2.2 Canada 18.104.22.168 High Burden of CVD in the Country is Contributing to the Growth of the Market in Canada 8.3 Europe 8.3.1 Germany 22.214.171.124 Germany Dominates the European Market 8.3.2 UK 126.96.36.199 Rising Support From Government and Private Organizations and Increasing Awareness Related to Defibrillators are Fueling Market Growth 8.3.3 France 188.8.131.52 Increasing Prevalence of Chronic Diseases in the Geriatric Population-A Key Driver for Market Growth in France 8.3.4 Italy 184.108.40.206 High Prevalence of Ohca in the Country is Driving the Growth of the Market 8.3.5 Spain 220.127.116.11 Increasing Number of Conferences and Awareness Programs is Supporting the Growth of the Market in Spain 8.3.6 Rest of Europe 8.4 Asia Pacific 8.4.1 Japan 18.104.22.168 Presence of A Universal Insurance Scheme in Japan is Expected to Support Market Growth 8.4.2 China 22.214.171.124 China is the Fastest-Growing Market for Defibrillators in the APAC 8.4.3 India 126.96.36.199 High Incidence and Prevalence of Cvd in the Country to Drive Market Growth 8.4.4 Australia 188.8.131.52 Government and Private Bodies are Taking Measures to Make Aeds Available at Public Sites in the Country 8.4.5 South Korea 184.108.40.206 Rising Incidence of Cardiac Disorders is Driving the Growth of the Defibrillators Market in South Korea 8.4.6 Rest of Asia Pacific (RoAPAC) 8.5 Latin America 8.5.1 Brazil 220.127.116.11 Large Obese Population has Resulted in the Increased Demand for Defibrillators in the Country 8.5.2 Mexico 18.104.22.168 High Prevalence of Target Diseases in the Country is the Major Factor Driving the Growth of the Market in Mexico 8.5.3 Rest of Latin America 8.6 Middle East & Africa
10 Company Profiles 10.1 Biotronik 10.1.1 Business Overview 10.1.2 Products Offered 10.1.3 Recent Developments (2016-2019) 10.2 Boston Scientific 10.3 CU Medical Systems 10.4 Koninklijke Philips N.V. 10.5 Mediana 10.6 Medtronic 10.7 Metsis Medikal 10.8 Microport 10.9 Mindray Medical 10.10 Nihon Kohden 10.11 Physio-Control (Part of Stryker Corporation) 10.12 Progetti Medical Equipment Solutions 10.13 Schiller AG 10.14 ST. Jude Medical (Acquired By Abbott Laboratories) 10.15 Zoll Medical Corporation (A Part of Asahi Kasei Corporation)